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Patient Education for 
Changing Guidelines
By: Richard Mendez
Collaboration with Tim Flanagan
UVMMC - South Burlington Family 
Practice
Problem Identification
In May 2012 United States Preventative Services Task Force (USPSTF) 
recommended against prostate cancer screening, Grade D, with no other 
recommendation for providers.1
Patients were exposed to previous guidelines during routine visits and lack of 
screening can cause concern.  
Prostate cancer continues to be among the most common cancer in the 
United States among men (101.6 per 100,000)2
Public Health Costs
• Medical costs associated with prostate cancer were estimated to be $12 
billion3
• Pro-rate estimates place Vermont’s medical costs associated with prostate 
cancer at 24 million due to Vermont representing 0.2% of the US population
• Unnecessary testing increases healthcare costs and potentially causes 
unnecessary worry in patient
Community Perspective
Dr. Scott Perrapato, UVMMC Associate Professor of Surgery, Division of 
Urology presented a September 6, 2016 community presentation on 
prostate cancer.  
Dr. Robert Luebbers expressed a need for increased education around 
prostate cancer screening as current patient information is limited
Dr. Whitney Calkins suggested a blog post on the UVMMC Family Medicine 
blog in order to target a larger audience due to the need for increased 
education
Proposed Intervention and Method
Patient education in an easily accessible handout for providers to distribute to 
patients that covers 3 main topics
Information to understand patient’s potential risk for prostate cancer
Education about PSA testing and current use of baseline PSA at 40 years old to determine future 
testing  
Suggest diet and exercise as a way to decrease prostate cancer risk
Response
• Result is a educational pamphlet that provides updated explanation with 
respected references for further education. 
• Educational pamphlets can be distributed to patients with their after visit 
summary and providing a better understanding of PSA screening
• Creating a dot-phrase provides physicians with a reminder about other useful 
dot-phrases throughout the system
Effectiveness and Limitations
• Effectiveness of patient information is a mix of utility to providers and utility 
to patients.
• Patients benefit from printed information that they can reread and further 
explore to better understand the physicians spoken explanation
• Handout provides links to respected resources for more in depth discussion
• Education promotes circular discussion with patients and physicians. 
Future Interventions
• Guidelines are constantly changing, therefore future projects should look at 
updating the educational pamphlet.
• Assess efficacy of providing information to patients in their AVS and if this 
information leads to more circular discussion regarding PSA screening
• Further dissemination of updated PSA screening through a UVMMC Family 
Medicine blog post. 
References
1. Final Update Summary: Prostate Cancer: Screening. U.S. Preventive Services 
Task Force. September 2016.
https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSu
mmaryFinal/prostate-cancer-screening
2. Cancer Among Men. Centers for Disease Control and Prevention. 
http://www.cdc.gov/cancer/dcpc/data/men.htm
3. Cancer costs projected to reach at least $158 billion in 2020. National 
Cancer Institute. http://www.cancer.gov/news-events/press-
releases/2011/costcancer2020 
